VanEck Genomics and Healthcare Innovators UCITS ETF EUR

ISIN IE000B9PQW54 · Ticker CURE · VanEck Asset Management B.V.

The VanEck Genomics and Healthcare Innovators UCITS ETF EUR. Ongoing charges are 0,35 % per year, the fund size is EUR 24 m. The distribution yield is 0,1 %.

Equity ETF · 99 % stocks
Cost p.a. 0,35 % ongoing charges
Fund size EUR 24 m converted to EUR
Distribution 0,1 % per provider data
Return 1 Y +21,6 % 3 Y p.a.: +13,9 %
Launched 2022since 2022-09-02
Exclusive to Finanzoo How good are the top 10 companies in this ETF?

The FScore rates each company from 0 to 100 on valuation, profitability, stability and dividend.

#Top 10 holdingWeightSectorFScore
1 Moderna Inc 10,6 % Healthcare -6,6
2 Regeneron Pharmaceuticals Inc 8,5 % Healthcare
3 Vertex Pharmaceuticals Inc 7,5 % Healthcare
4 Natera Inc 6,9 % Healthcare
5 Veeva Systems Inc Class A 6,8 % Healthcare
6 Illumina Inc 5,1 % Healthcare
7 DexCom Inc 4,7 % Healthcare
8 Guardant Health Inc 4,3 % Healthcare
9 BioNTech SE 3,3 % Healthcare
10 Alnylam Pharmaceuticals Inc 2,6 % Healthcare
Moderna Inc has an FScore of -6,6.How do the other top 10 companies score?
View all FScores – 7 days free

Composition

Regions

North America 93,2 %
Europe Developed 2,7 %
Asia Emerging 2,6 %
Australasia 2,3 %
Japan 1,3 %
United Kingdom 0,6 %

Sectors

Healthcare 100,0 %

Fact sheet

Official name
VanEck Genomics and Healthcare Innovators UCITS ETF EUR
Issuer
VanEck Asset Management B.V.
Domicile
Irland
Inception date
2022-09-02
Trading currency
EUR (XETRA)
Ongoing charges
0,35 % p.a.
Fund size
EUR 24 m

Valuation & risk Premium

P/E (forward)
P/B
P/CF
Volatility 3 Y
Sharpe ratio 3 Y
Beta
Unlock P/E, P/B, volatility and Sharpe ratio →

Similar ETFs with a higher avg. FScore Premium

0,26 %
0,36 %
0,49 %
Show better alternatives →
Retirement portfolio

Planning your retirement portfolio? Find the right second building block.

The planned standard portfolio uses two ETFs from different risk classes. Our presets show suitable equity and bond ETFs.

Presets in the ETF screener →

Frequently asked questions about VanEck Genomics and Healthcare Innovators UCITS ETF EUR

What are the costs of the VanEck Genomics and Healthcare Innovators UCITS ETF EUR?
Ongoing charges are 0,35 % per year.
Does the VanEck Genomics and Healthcare Innovators UCITS ETF EUR pay distributions?
According to provider data the distribution yield is 0,1 %.
How many holdings does the VanEck Genomics and Healthcare Innovators UCITS ETF EUR have?
The number of holdings is not available.
Is the VanEck Genomics and Healthcare Innovators UCITS ETF EUR suitable for a retirement portfolio?
That depends on your investment horizon and risk tolerance. Costs, diversification and the quality of the companies inside help with comparison. This is not investment advice.

Look inside every ETF – company by company.

FScore for 2.307 stocks and all ETFs, screener with all metrics, watchlist with FScore alerts and model portfolio.

Start free week → No credit card needed · No subscription after the free week

Data as of 2026-11-18. Returns in EUR; past performance is not an indicator of future results. Automated analysis, not investment advice. No guarantee for accuracy. All index and product names mentioned (e.g. MSCI®, S&P®, STOXX®, FTSE®) are trademarks of their respective owners and are used only to identify the ETF. Finanzoo is not affiliated with the index providers.